Cargando…

North Carolina pharmacists’ willingness to sell fentanyl test strips: a survey study

BACKGROUND: Although fentanyl test strips (FTS) can accurately determine the presence of fentanyl in unregulated substances, access to FTS remains limited. This study aimed to examine North Carolina community pharmacists’ attitudes and willingness to engage in various behaviors related to FTS sales...

Descripción completa

Detalles Bibliográficos
Autores principales: Marley, Grace T., Ostrach, Bayla, Carpenter, Delesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875410/
https://www.ncbi.nlm.nih.gov/pubmed/36694186
http://dx.doi.org/10.1186/s12954-023-00739-4
_version_ 1784877954269970432
author Marley, Grace T.
Ostrach, Bayla
Carpenter, Delesha
author_facet Marley, Grace T.
Ostrach, Bayla
Carpenter, Delesha
author_sort Marley, Grace T.
collection PubMed
description BACKGROUND: Although fentanyl test strips (FTS) can accurately determine the presence of fentanyl in unregulated substances, access to FTS remains limited. This study aimed to examine North Carolina community pharmacists’ attitudes and willingness to engage in various behaviors related to FTS sales and distribution. METHODS: A convenience sample of community pharmacists completed an online survey that assessed: (1) comfort initiating an FTS conversation; (2) willingness to sell FTS, distribute FTS instructions, counsel on FTS, refer patients to harm reduction organizations, and advertise FTS; (3) perceived barriers and benefits of selling FTS; and (4) interest in FTS training. Data were collected from March to May 2022. Descriptive statistics were calculated. RESULTS: Of the 592 pharmacists who participated, most were somewhat or very willing to refer patients to harm reduction organizations for FTS (514, 86.9%), counsel on FTS (485, 81.9%), distribute FTS instructions (475, 80.2%), sell FTS (470, 79.3%), and advertise FTS for sale (372, 62.9%). The most commonly reported benefits of selling FTS were reducing overdose deaths in the community (n = 482, 81.4%) and participating in community harm reduction efforts (n = 455; 76.9%). Barriers commonly reported to selling FTS were: not knowing where to order FTS (n = 295, 49.8%) and discomfort initiating a conversation about FTS (n = 266, 44.9%). Most respondents (88.3%) were interested in FTS training. CONCLUSION: North Carolina community pharmacists are willing to engage in various behaviors related to FTS sales and distribution. Most pharmacists were interested in receiving FTS training, which should be created to address pharmacist-reported barriers to FTS sales. Pharmacist distribution of FTS could increase access to FTS at the community level and has the potential to change drug use behavior and reduce overdose deaths. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12954-023-00739-4.
format Online
Article
Text
id pubmed-9875410
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98754102023-01-26 North Carolina pharmacists’ willingness to sell fentanyl test strips: a survey study Marley, Grace T. Ostrach, Bayla Carpenter, Delesha Harm Reduct J Brief Report BACKGROUND: Although fentanyl test strips (FTS) can accurately determine the presence of fentanyl in unregulated substances, access to FTS remains limited. This study aimed to examine North Carolina community pharmacists’ attitudes and willingness to engage in various behaviors related to FTS sales and distribution. METHODS: A convenience sample of community pharmacists completed an online survey that assessed: (1) comfort initiating an FTS conversation; (2) willingness to sell FTS, distribute FTS instructions, counsel on FTS, refer patients to harm reduction organizations, and advertise FTS; (3) perceived barriers and benefits of selling FTS; and (4) interest in FTS training. Data were collected from March to May 2022. Descriptive statistics were calculated. RESULTS: Of the 592 pharmacists who participated, most were somewhat or very willing to refer patients to harm reduction organizations for FTS (514, 86.9%), counsel on FTS (485, 81.9%), distribute FTS instructions (475, 80.2%), sell FTS (470, 79.3%), and advertise FTS for sale (372, 62.9%). The most commonly reported benefits of selling FTS were reducing overdose deaths in the community (n = 482, 81.4%) and participating in community harm reduction efforts (n = 455; 76.9%). Barriers commonly reported to selling FTS were: not knowing where to order FTS (n = 295, 49.8%) and discomfort initiating a conversation about FTS (n = 266, 44.9%). Most respondents (88.3%) were interested in FTS training. CONCLUSION: North Carolina community pharmacists are willing to engage in various behaviors related to FTS sales and distribution. Most pharmacists were interested in receiving FTS training, which should be created to address pharmacist-reported barriers to FTS sales. Pharmacist distribution of FTS could increase access to FTS at the community level and has the potential to change drug use behavior and reduce overdose deaths. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12954-023-00739-4. BioMed Central 2023-01-24 /pmc/articles/PMC9875410/ /pubmed/36694186 http://dx.doi.org/10.1186/s12954-023-00739-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Brief Report
Marley, Grace T.
Ostrach, Bayla
Carpenter, Delesha
North Carolina pharmacists’ willingness to sell fentanyl test strips: a survey study
title North Carolina pharmacists’ willingness to sell fentanyl test strips: a survey study
title_full North Carolina pharmacists’ willingness to sell fentanyl test strips: a survey study
title_fullStr North Carolina pharmacists’ willingness to sell fentanyl test strips: a survey study
title_full_unstemmed North Carolina pharmacists’ willingness to sell fentanyl test strips: a survey study
title_short North Carolina pharmacists’ willingness to sell fentanyl test strips: a survey study
title_sort north carolina pharmacists’ willingness to sell fentanyl test strips: a survey study
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875410/
https://www.ncbi.nlm.nih.gov/pubmed/36694186
http://dx.doi.org/10.1186/s12954-023-00739-4
work_keys_str_mv AT marleygracet northcarolinapharmacistswillingnesstosellfentanylteststripsasurveystudy
AT ostrachbayla northcarolinapharmacistswillingnesstosellfentanylteststripsasurveystudy
AT carpenterdelesha northcarolinapharmacistswillingnesstosellfentanylteststripsasurveystudy